An experimental blood test for pancreatic cancer that was developed by Van Andel Institute and University of Pittsburgh ...

New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of ...

An FDA committee’s September 2024 vote to limit the use of Merck’s Keytruda and BMS’ Opdivo in stomach and esophageal cancers ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that ...

An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients.

Currently, the state does not pay for the tests, meaning patients cannot receive any of a range of 40 drugs unless they pay ...

A total of 158 blood samples and 73 tumor tissue samples were sequenced using our designed panel covering 53 ... Our data may support future analyses of prognostic or predictive biomarkers for UC.

Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...

“A key objective of research focused on early-stage breast cancer is to identify biomarkers that can select patients who ...

Groundbreaking research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of lung ...